Skip to main content

Latest SEC Filings — Page 117

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

GSK's Momelotinib Receives Orphan Drug Designations for Life-Threatening VEXAS Syndrome
ProForm 6-KGSK · Form 6-K · 2026-06-12
Inventiva Details EIB Warrant Restructuring, Removes Anti-Dilution & Put Options
Form 6-KIVA · Form 6-K · 2026-06-12
CEO Chen Xiangdong Buys $447K in Company Stock Amidst Mixed Financials
Form 4GOTU · Form 4 · 2026-06-12
CEO Converts $160K Debt to Equity Amidst Going Concern Warning
ProForm 4COSM · Form 4 · 2026-06-12
JinkoSolar Declares $78.5M Cash Dividend ($1.50/ADS)
ProForm 6-KJKS · Form 6-K · 2026-06-12
HUTCHMED Presents Strong Phase III Data for Sovleplenib in wAIHA at EHA, Reinforcing China NDA Priority Review
ProForm 6-KHCM · Form 6-K · 2026-06-12
Viatris Files Preliminary Prospectus for Euro Senior Notes to Refinance $1.675 Billion Debt
Form 424B5VTRS · Form 424B5 · 2026-06-12
Shareholders Approve $90.4M Total Dividend, New Buyback & Issuance Mandates at AGM
ProForm 6-KNOAH · Form 6-K · 2026-06-12
Alterity Therapeutics Completes 1-for-50 Reverse Stock Split
ProForm 6-KATHE · Form 6-K · 2026-06-12
Braemar Hotels & Resorts to become self-managed REIT, terminate Ashford advisory, and reconstitute board
ProForm 8-KBHR · Form 8-K · 2026-06-12
AngloGold Ashanti Sets Shareholder Meeting for $2.0B Repurchase Program Approval
Form 6-KAU · Form 6-K · 2026-06-12
AES Prices $1 Billion Senior Notes Offering
ProForm FWPAES · Form FWP · 2026-06-12
C21 Investments Reports Strong FY26 Growth Amidst $15M Uncertain Tax Liability
ProForm 6-KCXXIF · Form 6-K · 2026-06-12
Future Vision II Secures Another Sponsor Loan to Extend Merger Deadline to July 13
ProForm 8-KFVN · Form 8-K · 2026-06-12
Shareholders Reject Executive Compensation at Annual Meeting
Form 8-KJAKK · Form 8-K · 2026-06-12
Flutter to Delist from London Stock Exchange, Consolidating Listing on NYSE
ProForm 8-KFLUT · Form 8-K · 2026-06-12
Woodside Exercises Pre-emption Right to Acquire 10.67% Stake in Browse Gas Project for up to $400M
ProForm 6-KWDS · Form 6-K · 2026-06-12
AIFU Inc. Finalizes 1-for-20 Reverse Stock Split Effective June 16
ProForm 6-KAIFU · Form 6-K · 2026-06-12
NEONC Technologies Agrees to Sell $5M in Highly Dilutive Convertible Preferred Stock
ProForm 8-KNTHI · Form 8-K · 2026-06-12
Evaxion's AI-Immunology™ Platform Wins Prestigious Prix Galien UK Award
Form 6-KEVAX · Form 6-K · 2026-06-12
HF Foods Adopts Poison Pill Amidst Shareholder Discontent
ProForm 8-KHFFG · Form 8-K · 2026-06-12
Qorvo Secures Noteholder Consents for $1.55B Debt Exchange Ahead of Skyworks Merger
ProForm 8-KQRVO · Form 8-K · 2026-06-12
Qorvo Debt Exchange Offers See High Participation, Covenants Eliminated Ahead of Skyworks Merger
ProForm 425QRVO · Form 425 · 2026-06-12
Skyworks Reports Strong Early Participation in Qorvo Debt Exchange Offers
ProForm 8-KSWKS · Form 8-K · 2026-06-12
Former Director Affiliate Files Intent to Sell $34.5M in BANC Stock
Form 144BANC · Form 144 · 2026-06-12
D. E. Shaw & Co. Becomes 9.5% Owner, Backs Dilutive Restructuring Plan
ProForm SCHEDULE 13DGOSS · Form SCHEDULE 13D · 2026-06-12
Afya VP of Digital Services Files to Sell $1.14M in Shares
Form 144AFYA · Form 144 · 2026-06-12
Redmile Group Increases Stake to 9.9% with $8.4M Investment in Shattuck Labs
ProForm SCHEDULE 13D/ASTTK · Form SCHEDULE 13D/A · 2026-06-12
Director and 10% Owner Sells $2.25M in Silvaco Group Stock
Form 4SVCO · Form 4 · 2026-06-12
RA Capital Healthcare Fund Sells $253K in Werewolf Therapeutics Stock
Form 4HOWL · Form 4 · 2026-06-12